Topic: Patient Reported Outcomes
The partners will study patient-focused endpoints alongside so-called “hard outcomes" that have traditionally served as endpoints in clinical trials.
ICER is considering charging biotech companies for early scientific advice and direct guidance in clinical trial design.
Thursday, September 13, 2018
Navigating patient-reported outcomes (PROs) such as unobservable symptoms, treatment satisfaction, quality of life, and treatment adherence is a critical component of a patient centric healthcare system. Join our experts in the first of a three-part webinar series on PROs, as they provide insight on the foundational elements of PROs and recent regulatory trends.
Parexel has set up a team committed to providing real-world data insights.
Icon strengthens real-world evidence offerings by acquiring health research and commercialization company Mapi.
BeiGene is adding Medidata’s electronic patient-reported outcome solution to oncology clinical studies.
SynteractHCR has hired Steve Powell, who has years of experience on electronic data as a senior executive at Exco InTouch and PRA Health Sciences.
WIRB-Copernicus Group continued an acquisition spree with purchases of electronic clinical outcome assessments specialists MedAvante and ProPhase.
Former FDA commissioner Robert Califf, who was not asked back into his role by President Donald Trump, has become the new chair of the newly formed People-Centered Research Foundation (PCRF).
The U.S. FDA selects Icon to validate three patient-reported outcome (PRO) instruments used to assess clinical endpoints in antibacterial drug trials.